Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review.
Mastronardi M, Cavalcanti E, Labarile N, Armentano R, Gabriele F, Curlo M. Mastronardi M, et al. Among authors: curlo m. Ther Adv Chronic Dis. 2023 Nov 3;14:20406223231194190. doi: 10.1177/20406223231194190. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 37928629 Free PMC article.
Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease.
Mastronardi M, Curlo M, Cavalcanti E, Burattini O, Cuppone R, Tauro R, De Santis S, Serino G, Pesole PL, Stasi E, Caruso ML, Donghia R, Guerra V, Giorgio P, Chieppa M. Mastronardi M, et al. Among authors: curlo m. Front Med (Lausanne). 2019 Nov 1;6:234. doi: 10.3389/fmed.2019.00234. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31737635 Free PMC article.
Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study.
Liso M, Sila A, Verna G, Scarano A, Donghia R, Castellana F, Cavalcanti E, Pesole PL, Sommella EM, Lippolis A, Armentano R, Giudetti AM, Vergara D, Campiglia P, Sardone R, Curlo M, Mastronardi M, Petroni K, Tonelli C, Santino A, Chieppa M. Liso M, et al. Among authors: curlo m. Antioxidants (Basel). 2022 Jan 8;11(1):138. doi: 10.3390/antiox11010138. Antioxidants (Basel). 2022. PMID: 35052642 Free PMC article.
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.
Bianchi FP, Polignano M, Carella N, Rotolo O, Curlo M, Mastronardi M. Bianchi FP, et al. Among authors: curlo m. Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16. Hum Vaccin Immunother. 2024. PMID: 38755111 Review.
Evaluation of Antibiotic Resistance of Helicobacter pylori Strains Isolated in Bari, Southern Italy, in 2017-2018 by Phenotypic and Genotyping Methods.
Palmitessa V, Monno R, Panarese A, Cuppone R, Burattini O, Marangi S, Curlo M, Fumarola L, Petrosillo A, Parisi A, Capozzi L, Bianco A, Lippolis A. Palmitessa V, et al. Among authors: curlo m. Microb Drug Resist. 2020 Aug;26(8):909-917. doi: 10.1089/mdr.2019.0262. Epub 2020 Feb 26. Microb Drug Resist. 2020. PMID: 32101078
11 results